Vascular access-related bloodstream infections in first nations, community and teaching canadian dialysis units, and other centre-level predictors

Nephron - Clinical Practice

Volumn 114, Issue 3, 2010, Pages

  Lafrance, Jean Philippe ^a   Iqbal, Sameena ^a   Lelorier, Jacques ^b   Dasgupta, Kaberi ^a   Ritchie, Judith ^c   Ward, Linda ^c   Benaroya, Samuel ^a   Barré, Paul ^a   Cantarovich, Marcelo ^d   Ghannoum, Marc ^e   Proulx, Normand ^f   Vasilevsky, Murray ^a   Rahme, Elham ^a  

^a MCGILL UNIVERSITY   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c Université de Montréal ^*  (United States)

^d MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^e Centre Hospitalier de Verdun   (Canada)

^f Neurochirurgien et Chirurgien de la Colonne Hôpital de Hull   (Canada)

Author keywords

Arteriovenous fistula; Catheter related infections; Epidemiology; Hemodialysis; Vascular access

Indexed keywords

ADULT; AGED; ARTERIOVENOUS FISTULA; ARTERIOVENOUS GRAFT; ARTICLE; BLOOD VESSEL GRAFT; BLOODSTREAM INFECTION; CANADA; CATHETER INFECTION; CENTRAL VENOUS CATHETER; COHORT ANALYSIS; COMMUNITY HOSPITAL; CONTROLLED STUDY; ENTEROCOCCAL INFECTION; FEMALE; FOLLOW UP; GRAM NEGATIVE INFECTION; GRAM POSITIVE INFECTION; HEMODIALYSIS; HUMAN; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; STAPHYLOCOCCUS INFECTION; SURVIVAL; TEACHING HOSPITAL; VASCULAR ACCESS;

AGED; CANADA; CATHETERIZATION, CENTRAL VENOUS; COMMUNITY HEALTH CENTERS; COMORBIDITY; CROSS INFECTION; EXTRACORPOREAL CIRCULATION; FEMALE; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RENAL DIALYSIS; RISK ASSESSMENT; RISK FACTORS;

EID: 70849135960     PISSN: 16602110     EISSN: None     Source Type: Journal    
DOI: 10.1159/000262303     Document Type: Article

References (41)

1. Canadian Institute for Health Information. Treatment of End-Stage Organ Failure in Canada, 1996 to 2005 (2007 Annual Report). Ottawa: Canadian Institute for Health Information; 2007
2. U.S. Renal Data System. USRDS 2007 Annual Data Report: Atlas of Chronic Kidney Disease & End-Stage Renal Disease in the United States. Bethesda: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2007
3. Marr KA, Sexton DJ, Conlon PJ, Corey GR, Schwab SJ, Kirkland KB: Catheter-related bacteremia and outcome of attempted catheter salvage in patients undergoing hemodialysis. Ann Intern Med 1997; 127: 275-280
4. Beathard GA: Management of bacteremia associated with tunneled-cuffed hemodialysis catheters. J Am Soc Nephrol 1999; 10: 1045-1049
5. Saad TF: Bacteremia associated with tunneled, cuffed hemodialysis catheters. Am J Kidney Dis 1999; 34: 1114-1124
6. Stevenson KB, Adcox MJ, Mallea MC, Narasimhan N, Wagnild JP: Standardized surveillance of hemodialysis vascular access infections: 18-month experience at an outpatient, multifacility hemodialysis center. Infect Control Hosp Epidemiol 2000; 21: 200-203
7. Little MA, O'Riordan A, Lucey B, et al: A prospective study of complications associated with cuffed, tunnelled haemodialysis catheters. Nephrol Dial Transplant 2001; 16: 2194-2200
8. Dopirak M, Hill C, Oleksiw M, et al: Surveillance of hemodialysis- associated primary bloodstream infections: the experience of ten hospital-based centers. Infect Control Hosp Epidemiol 2002; 23: 721-724
9. Jean G, Charra B, Chazot C, et al: Risk factor analysis for long-term tunneled dialysis catheter-related bacteremias. Nephron 2002; 91: 399-405
10. Krishnasami Z, Carlton D, Bimbo L, et al: Management of hemodialysis catheter-related bacteremia with an adjunctive antibiotic lock solution. Kidney Int 2002; 61: 1136-1142
11. Saeed Abdulrahman I, Al-Mueilo SH, Bokhary HA, Ladipo GO, Al-Rubaish A: A prospective study of hemodialysis access-related bacterial infections. J Infect Chemother 2002; 8: 242-246
12. Stevenson KB, Hannah EL, Lowder CA, et al: Epidemiology of hemodialysis vascular access infections from longitudinal infection surveillance data: predicting the impact of NKF-DOQI clinical practice guidelines for vascular access. Am J Kidney Dis 2002; 39: 549-555
13. Taylor G, Gravel D, Johnston L, Embil J, Holton D, Paton S: Prospective surveillance for primary bloodstream infections occurring in Canadian hemodialysis units. Infect Control Hosp Epidemiol 2002; 23: 716-720
14. Tokars JI, Miller ER, Stein G: New national surveillance system for hemodialysis-associated infections: initial results. Am J Infect Control 2002; 30: 288-295
15. Poole CV, Carlton D, Bimbo L, Allon M: Treatment of catheter-related bacteraemia with an antibiotic lock protocol: effect of bacterial pathogen. Nephrol Dial Transplant 2004; 19: 1237-1244
16. Taylor G, Gravel D, Johnston L, Embil J, Holton D, Paton S: Incidence of bloodstream infection in multicenter inception cohorts of hemodialysis patients. Am J Infect Control 2004; 32: 155-160
17. Develter W, De Cubber A, Van Biesen W, Vanholder R, Lameire N: Survival and complications of indwelling venous catheters for permanent use in hemodialysis patients. Artif Organs 2005; 29: 399-405
18. Aslam N, Lambie M, Ayub V, Stein A: Use of tunnelled haemodialysis catheters at the start of haemodialysis-success rates and definition of infection. Nephrol Dial Transplant 2007; 22: 1799-1800
19. Sedlacek M, Gemery JM, Cheung AL, Bayer AS, Remillard BD: Aspirin treatment is associated with a significantly decreased risk of Staphylococcus aureus bacteremia in hemodialysis patients with tunneled catheters. Am J Kidney Dis 2007; 49: 401-408
20. Hoen B, Paul-Dauphin A, Hestin D, Kessler M: EPIBACDIAL: a multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients. J Am Soc Nephrol 1998; 9: 869-876
21. Tokars JI, Light P, Anderson J, et al: A prospective study of vascular access infections at seven outpatient hemodialysis centers. Am J Kidney Dis 2001; 37: 1232-1240
22. Welcome to RUIS McGill. 2008. http://www. medicine.mcgill.ca/ruis/ (accessed July 25, 2008)
23. Vascular Access Work Group: Clinical practice guidelines for vascular access. Am J Kidney Dis 2006; 48(suppl 1):S248-S273
24. Pearson ML: Guideline for prevention of intravascular device-related infections. Part I. Intravascular device-related infections: an overview. The Hospital Infection Control Practices Advisory Committee. Am J Infect Control 1996; 24: 262-277
25. Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM: CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988; 16: 128-140
26. Vascular Access 2006 Work Group: Clinical practice guidelines for vascular access. Am J Kidney Dis 2006; 48(suppl 1):S176-S247
27. Allon M: Current management of vascular access. Clin J Am Soc Nephrol 2007; 2: 786-800
28. Boelaert JR, Van Landuyt HW, Godard CA, et al: Nasal mupirocin ointment decreases the incidence of Staphylococcus aureus bacteraemias in haemodialysis patients. Nephrol Dial Transplant 1993; 8: 235-239
29. Falagas ME, Bliziotis IA, Fragoulis KN: Oral rifampin for eradication of Staphylococcus aureus carriage from healthy and sick populations: a systematic review of the evidence from comparative trials. Am J Infect Control 2007; 35: 106-114
30. Falagas ME, Fragoulis KN, Bliziotis IA: Oral rifampin for prevention of S. aureus carriage- related infections in patients with renal failure-a meta-analysis of randomized controlled trials. Nephrol Dial Transplant 2006; 21: 2536-2542
31. Jaffer Y, Selby NM, Taal MW, Fluck RJ, Mc- Intyre CW: A meta-analysis of hemodialysis catheter locking solutions in the prevention of catheter-related infection. Am J Kidney Dis 2008; 51: 233-241
32. Johnson DW, MacGinley R, Kay TD, et al: A randomized controlled trial of topical exit site mupirocin application in patients with tunnelled, cuffed haemodialysis catheters. Nephrol Dial Transplant 2002; 17: 1802-1807
33. Johnson DW, van Eps C, Mudge DW, et al: Randomized, controlled trial of topical exitsite application of honey (Medihoney) versus mupirocin for the prevention of catheter-associated infections in hemodialysis patients. J Am Soc Nephrol 2005; 16: 1456-1462
34. Kluytmans JA, Manders MJ, van Bommel E, Verbrugh H: Elimination of nasal carriage of Staphylococcus aureus in hemodialysis patients. Infect Control Hosp Epidemiol 1996; 17: 793-797
35. Lok CE, Stanley KE, Hux JE, Richardson R, Tobe SW, Conly J: Hemodialysis infection prevention with polysporin ointment. J Am Soc Nephrol 2003; 14: 169-179
36. Fay MP, Feuer EJ: Confidence intervals for directly standardized rates: a method based on the gamma distribution. Stat Med 1997; 16: 791-801
37. Greenland S: Analysis of polytomous exposures and outcomes; in Rothman KJ, Greenland S, Lash TL (eds). Modern Epidemiology, ed 3. Philadelphia, Lippincott Williams & Wilkins, 2008, pp 303-327
38. van Buuren S, Boshuizen HC, Knook DL: Multiple imputation of missing blood pressure covariates in survival analysis. Stat Med 1999; 18: 681-694
39. Lafrance JP, Rahme E, Lelorier J, Iqbal S: Vascular access-related infections: definitions, incidence rates, and risk factors. Am J Kidney Dis 2008; 52: 982-993
40. Ethier J, Mendelssohn DC, Elder SJ, et al: Vascular access use and outcomes: an international perspective from the Dialysis Outcomes and Practice Patterns Study. Nephrol Dial Transplant 2008; 23: 3219-3226
41. NKF-DOQI clinical practice guidelines for vascular access. National Kidney Foundation- Dialysis Outcomes Quality Initiative. Am J Kidney Dis 1997; 30(suppl 3):S150-S191